ImClone System's finance-meister is jumping ship, the company announced. And no, it's not your imagination--Ana Stancic's departure will make ImClone the sixth biopharma company to lose its finance chief in recent months. FiercePharma [1]
Links:
[1] http://www.fiercepharma.com/story/imclone-finance-chief-jumps-ship/2007-08-24